Abstract:The ketogenic diet, characterized by high fat and low carbohydrates, has gained popularity not only as a strategy for managing body weight but also for its efficacy in delaying cognitive decline associated with neurodegenerative diseases and the aging process. Since this dietary approach stimulates the liver's production of ketone bodies, primarily β-hydroxybutyrate (BHB), which serves as an alternative energy source for neurons, we investigated whether BHB could mitigate impaired AMPA receptor trafficking, synaptic dysfunction, and cognitive decline induced by metabolic challenges such as saturated fatty acids. Here, we observe that, in cultured primary cortical neurons, exposure to palmitic acid (200μM) decreased surface levels of glutamate GluA1-containing AMPA receptors, whereas unsaturated fatty acids, such as oleic acid and ω-3 docosahexaenoic acid (200μM), and BHB (5mM) increased them. Furthermore, BHB countered the adverse effects of palmitic acid on synaptic GluA1 levels in hippocampal neurons, as well as excitability and plasticity in hippocampal slices. Additionally, daily intragastric administration of BHB (100 mg/kg/day) for two months reversed cognitive impairment induced by a saturated high-fat diet (49% of calories from fat) in a mouse experimental model of obesity. In summary, our findings underscore the significant impact of fatty acids and ketone bodies on AMPA receptors abundance, synaptic function and neuroplasticity, shedding light on the potential use of BHB to delay cognitive impairments associated with metabolic diseases.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the negative effects of a saturated high - fat diet on synaptic AMPA receptors and cognitive performance, and to explore whether β - hydroxybutyric acid (BHB) can counteract these adverse effects. Specifically, the researchers focused on: 1. **The influence of saturated fatty acids**: How saturated fatty acids (such as palmitic acid) affect the level of AMPA receptors on the neuronal surface, and how this influence leads to synaptic dysfunction and cognitive decline. 2. **The role of BHB**: As a ketone body, whether BHB can reverse the decrease in the surface level of AMPA receptors, synaptic dysfunction and cognitive decline caused by saturated fatty acids. ### Research background - **The relationship between cognitive impairment and nutrition**: With the increasing global incidence of cognitive impairment and dementia, more and more studies have begun to focus on the impact of nutrition on brain health. In particular, the intake of saturated fatty acids (SFA) is related to memory decline. - **The importance of AMPA receptors**: AMPA receptors play a crucial role in synaptic plasticity and cognitive processes. Changes in their surface levels will affect synaptic function and the stability of neural networks. - **The role of ketone bodies**: Ketone bodies (especially BHB) are produced in a low - carbohydrate and high - fat diet (such as a ketogenic diet) and can serve as an alternative energy source for neurons, which helps to delay cognitive decline associated with aging and neurodegenerative diseases. ### Main findings - **In vitro experiments**: - Palmitic acid (PA) treatment reduced the GluA1 level on the surface of cortical neurons, while monounsaturated fatty acids (such as oleic acid) and polyunsaturated fatty acids (such as DHA) as well as BHB increased the GluA1 level. - BHB was able to reverse the decrease in the GluA1 level on the surface of hippocampal neurons caused by PA, while improving synaptic transmission and plasticity. - **In vivo experiments**: - In a mouse model, a high - saturated - fat diet (49% of calories from fat) led to a decline in cognitive function, and daily oral administration of BHB (100 mg/kg/day) could reverse this cognitive impairment. - BHB was also able to reduce the weight gain caused by a high - saturated - fat diet, especially with a significant effect in male mice. ### Conclusion This study reveals the potential role of BHB in counteracting synaptic dysfunction and cognitive decline caused by saturated fatty acids. This provides a scientific basis for the development of new strategies to prevent and treat cognitive impairment associated with metabolic diseases.

BETA-HYDROXYBUTYRATE COUNTERACTS THE DELETERIOUS EFFECTS OF A SATURATED HIGH-FAT DIET ON SYNAPTIC AMPA RECEPTORS AND COGNITIVE PERFORMANCE

BETA-HYDROXYBUTYRATE COUNTERACTS THE DELETERIOUS EFFECTS OF A SATURATED HIGH-FAT DIET ON SYNAPTIC AMPA RECEPTORS AND COGNITIVE PERFORMANCE

Modulation of the autophagy‐lysosomal pathway and endoplasmic reticulum stress by ketone bodies in experimental models of stroke

The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer’s mouse model and stimulates synaptic plasticity pathway enzymes

Butyric Acid Precursor Tributyrin Modulates Hippocampal Synaptic Plasticity and Prevents Spatial Memory Deficits: Role of PPARγ and AMPK

Effect of the Ketone Body, D-β-Hydroxybutyrate, on Sirtuin2-Mediated Regulation of Mitochondrial Quality Control and the Autophagy–Lysosomal Pathway

Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease

Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer’s Disease

Differential Response of Hippocampal and Cerebrocortical Autophagy and Ketone Body Metabolism to the Ketogenic Diet

Ketogenic interventions restore cognition and modulate peripheral metabolic dysfunctions in Alzheimer’s disease mouse models

Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders.

Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

Treatment with the Ketone Body D-β-hydroxybutyrate Attenuates Autophagy Activated by NMDA and Reduces Excitotoxic Neuronal Damage in the Rat Striatum In Vivo

Metabolic Disturbance of High-Saturated Fatty Acid Diet in Cognitive Preservation

Ketogenic diet: a nutritional protocol for a non-pharmacological treatment of Alzheimer’s disease

A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study

Ketogenic β‐hydroxybutyrate regulates β‐hydroxybutyrylation of TCA cycle‐associated enzymes and attenuates disease‐associated pathologies in Alzheimer's mice

Ketogenic Diet Ameliorates Cognitive Impairment and Neuroinflammation in a Mouse Model of Alzheimer’s Disease

Ketosis Elevates Antioxidants and Enhances Neural Function Through Improved Bioenergetics: A H MR Spectroscopy Study